The Discovery of Potent and Long-Acting Oral Factor Xa Inhibitors with Tetrahydroisoquinoline and Benzazepine P4 Motifs.
Watson, N.S., Adams, C., Belton, D., Brown, D., Burns-Kurtis, C.L., Chaudry, L., Chan, C., Convery, M.A., Davies, D.E., Exall, A.M., Harling, J.D., Irvine, S., Irving, W.R., Kleanthous, S., Mclay, I.M., Pateman, A.J., Patikis, A.N., Roethke, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Young, R.J.(2011) Bioorg Med Chem Lett 21: 1588
- PubMed: 21349711 
- DOI: https://doi.org/10.1016/j.bmcl.2011.01.129
- Primary Citation of Related Structures:  
2Y7X - PubMed Abstract: 
The discovery and evaluation of potent and long-acting oral sulfonamidopyrrolidin-2-one factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs are described. Unexpected selectivity issues versus tissue plasminogen activator in the former series were addressed in the later, delivering a robust candidate for progression towards clinical studies ...